Palatin Technologies Inc PTN:NYSE American

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 10/22/21 EDT
0.41quote price arrow down-0.01 (-2.27%)
Volume
712,854
Close
0.4145quote price arrow down-0.0205 (-4.7126%)
Volume
1,828,725
52 week range
0.38 - 1.30
Loading...
  • Open0.435
  • Day High0.4389
  • Day Low0.4004
  • Prev Close0.435
  • 52 Week High1.30
  • 52 Week High Date02/10/21
  • 52 Week Low0.38
  • 52 Week Low Date10/28/20

Key Stats

  • Market Cap95.86M
  • Shares Out231.26M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.16
  • YTD % Change-38.67

KEY STATS

  • Open0.435
  • Day High0.4389
  • Day Low0.4004
  • Prev Close0.435
  • 52 Week High1.30
  • 52 Week High Date02/10/21
  • 52 Week Low0.38
  • 52 Week Low Date10/28/20
  • Market Cap95.86M
  • Shares Out231.26M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.16
  • YTD % Change-38.67

RATIOS/PROFITABILITY

  • EPS (TTM)-0.14
  • P/E (TTM)-2.92
  • Fwd P/E (NTM)-3.03
  • EBITDA (TTM)-30.549M
  • ROE (TTM)-51.76%
  • Revenue (TTM)-190,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-19,006.72%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/15/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Palatin Technologies Inc

There is no recent news for this security.

Profile

MORE
Palatin Technologies, Inc. (Palatin) is a biopharmaceutical company. The Company is engaged in developing medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. The Company’s product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical need and commercial potential. The melanocortin receptor (MCr) system is hormone driven, with effects on food intake, metabolism...
John Prendergast Ph.D.
Non-Executive Chairman
Carl Spana Ph.D.
President
Stephen Wills CPA
Chief Financial Officer
Address
4B Cedar Brook Drive
Cranbury, NJ
08512
United States

Top Peers

SYMBOLLASTCHG%CHG
TPST
Tempest Therapeutics Inc
12.15-1.41-10.40%
LPCN
Lipocine Inc
1.06-0.03-2.75%
ITRM
Iterum Therapeutics PLC
0.5221-0.0311-5.6218%
LYRA
Lyra Therapeutics Inc
7.84-0.10-1.26%
MTCR
Metacrine, Inc.
1.63-2.20-57.44%